Host factors and genetic susceptibility to infections due to intracellular bacteria and fastidious organisms

Clinical Microbiology and Infection

Volumn 20, Issue 12, 2014, Pages 1246-1253

  Asner, S A ^a   Morre S A ^b,c   Bochud, P Y ^a   Greub, G ^a,d  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

C. burnetii; C. psittaci; C. trachomatis; Genotyping; Host genetics; Intracellular bacteria; M. pneumoniae; Molecular diagnosis; Mycobacteria; Risk factors; T. whipplei

Indexed keywords

HOST FACTOR;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL MIGRATION; CHILD; CHLAMYDIA PSITTACI; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; COXIELLA BURNETII; CYTOKINE RELEASE; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; INTESTINE LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NONHUMAN; ORNITHOSIS; PHAGOCYTE; PRIORITY JOURNAL; Q FEVER; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; TH1 CELL; TUBERCULOSIS; BACTERIUM; GENETICS; IMMUNOLOGY; PATHOGENICITY;

BACTERIA (MICROORGANISMS); CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CORYNEBACTERINEAE; MYCOPLASMA PNEUMONIAE;

ADULT; BACTERIA; BACTERIAL INFECTIONS; CHILD; GENETIC PREDISPOSITION TO DISEASE; HUMANS;

EID: 84920400568     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12806     Document Type: Article

References (83)

1. Delaloye J, Greub G. [Q fever, a zoonosis often overlooked]. Rev Med Suisse 2013; 9: 879-884.
2. Raoult D, Marrie T, Mege J. Natural history and pathophysiology of Q fever. Lancet Infect Dis 2005; 5: 219-226.
3. Roest HI, Ruuls RC, Tilburg JJ et al. Molecular epidemiology of Coxiella burnetii from ruminants in Q fever outbreak, the Netherlands. Emerg Infect Dis 2011; 17: 668-675.
4. Bellini C, Magouras I, Chapuis-Taillard C, et al. Q fever outbreak in the terraced vineyards of Lavaux. Switzerland. New Microbes New Infect 2014; 2: 93-99.
5. Abel L, El-Baghdadi J, Bousfiha AA, Casanova JL, Schurr E. Human genetics of tuberculosis: a long and winding road. Philos Trans R Soc Lond B Biol Sci 2014; 369: 20130428.
6. El Baghdadi J, Grant AV, Sabri A et al. Human genetics of tuberculosis. Pathol Biol (Paris) 2013; 61: 11-16.
7. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002; 20: 581-620.
8. Stead WW, Senner JW, Reddick WT, Lofgren JP. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N Engl J Med 1990; 322: 422-427.
9. Comstock GW. Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis 1978; 117: 621-624.
10. Jepson A, Fowler A, Banya W et al. Genetic regulation of acquired immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa. Infect Immun 2001; 69: 3989-3994.
11. Sepulveda RL, Heiba IM, King A, Gonzalez B, Elston RC, Sorensen RU. Evaluation of tuberculin reactivity in BCG-immunized siblings. Am J Respir Crit Care Med 1994; 149: 620-624.
12. Thye T, Browne EN, Chinbuah MA et al. IL10 haplotype associated with tuberculin skin test response but not with pulmonary TB. PLoS One 2009; 4: e5420.
13. Stein CM, Zalwango S, Malone LL et al. Genome scan of M. tuberculosis infection and disease in Ugandans. PLoS One 2008; 3: e4094.
14. Alcais A, Fieschi C, Abel L, Casanova JL. Tuberculosis in children and adults: two distinct genetic diseases. J Exp Med 2005; 202: 1617-1621.
15. Boisson-Dupuis S, El Baghdadi J, Parvaneh N et al. IL-12Rbeta1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and Turkey. PLoS One 2011; 6: e18524.
16. Caragol I, Raspall M, Fieschi C et al. Clinical tuberculosis in 2 of 3 siblings with interleukin-12 receptor beta1 deficiency. Clin Infect Dis 2003; 37: 302-306.
17. Ozbek N, Fieschi C, Yilmaz BT et al. Interleukin-12 receptor beta 1 chain deficiency in a child with disseminated tuberculosis. Clin Infect Dis 2005; 40: e55-e58.
18. Moller M, de Wit E, Hoal EG. Past, present and future directions in human genetic susceptibility to tuberculosis. FEMS Immunol Med Microbiol 2010; 58: 3-26.
19. Azad AK, Sadee W, Schlesinger LS. Innate immune gene polymorphisms in tuberculosis. Infect Immun 2012; 80: 3343-3359.
20. Gao L, Tao Y, Zhang L, Jin Q. Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. Int J Tuberc Lung Dis 2010; 14: 15-23.
21. Lewis SJ, Baker I, Davey Smith G. Meta-analysis of vitamin D receptor polymorphisms and pulmonary tuberculosis risk. Int J Tuberc Lung Dis 2005; 9: 1174-1177.
22. Ma MJ, Xie LP, Wu SC et al. Toll-like receptors, tumor necrosis factor-alpha, and interleukin-10 gene polymorphisms in risk of pulmonary tuberculosis and disease severity. Hum Immunol 2010; 71: 1005-1010.
23. Vejbaesya S, Chierakul N, Luangtrakool K, Srinak D, Stephens HA. Associations of HLA class II alleles with pulmonary tuberculosis in Thais. Eur J Immunogenet 2002; 29: 431-434.
24. Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998; 338: 640-644.
25. Li HT, Zhang TT, Zhou YQ, Huang QH, Huang J. SLC11A1 (formerly NRAMP1) gene polymorphisms and tuberculosis susceptibility: a meta-analysis. Int J Tuberc Lung Dis 2006; 10: 3-12.
26. Malik S, Abel L, Tooker H et al. Alleles of the NRAMP1 gene are risk factors for pediatric tuberculosis disease. Proc Natl Acad Sci USA 2005; 102: 12183-12188.
27. Grant AV, El Baghdadi J, Sabri A et al. Age-dependent association between pulmonary tuberculosis and common TOX variants in the 8q12-13 linkage region. Am J Hum Genet 2013; 92: 407-414.
28. Aliahmad P, Seksenyan A, Kaye J. The many roles of TOX in the immune system. Curr Opin Immunol 2012; 24: 173-177.
29. Aliahmad P, Kaye J. Development of all CD4 T lineages requires nuclear factor TOX. J Exp Med 2008; 205: 245-256.
30. Thye T, Vannberg FO, Wong SH et al. Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nat Genet 2010; 42: 739-741.
31. Thye T, Owusu-Dabo E, Vannberg FO et al. Common variants at 11p13 are associated with susceptibility to tuberculosis. Nat Genet 2012; 44: 257-259.
32. Chimusa ER, Zaitlen N, Daya M et al. Genome-wide association study of ancestry-specific TB risk in the South African Coloured population. Hum Mol Genet 2014; 23: 796-809.
33. Greenwood CM, Fujiwara TM, Boothroyd LJ et al. Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family. Am J Hum Genet 2000; 67: 405-416.
34. Miyairi I, Mahdi OS, Ouellette SP, Belland RJ, Byrne GI. Different growth rates of Chlamydia trachomatis biovars reflect pathotype. J Infect Dis 2006; 194: 350-357.
35. Miyairi I, Ziebarth J, Laxton JD et al. Host genetics and Chlamydia disease: prediction and validation of disease severity mechanisms. PLoS One 2012; 7: e33781.
36. Abdelrahman YM, Belland RJ. The chlamydial developmental cycle. FEMS Microbiol Rev 2005; 29: 949-959.
37. Carlson JH, Hughes S, Hogan D et al. Polymorphisms in the Chlamydia trachomatis cytotoxin locus associated with ocular and genital isolates. Infect Immun 2004; 72: 7063-7072.
38. Al-Kuhlani M, Rothchild J, Pal S et al. TRAIL-R1 is a negative regulator of pro-inflammatory responses and modulates long-term sequelae resulting from Chlamydia trachomatis infections in humans. PLoS One 2014; 9: e93939.
39. Malogajski J, Brankovic I, Verweij SP et al. Translational potential into health care of basic genomic and genetic findings for human immunodeficiency virus, Chlamydia trachomatis, and human papilloma virus. Biomed Res Int 2013; 2013: 892106.
40. Morre SA, Karimi O, Ouburg S. Chlamydia trachomatis: identification of susceptibility markers for ocular and sexually transmitted infection by immunogenetics. FEMS Immunol Med Microbiol 2009; 55: 140-153.
41. Lal JA, Malogajski J, Verweij SP et al. Chlamydia trachomatis infections and subfertility: opportunities to translate host pathogen genomic data into public health. Public Health Genomics 2013; 16: 50-61.
42. Ouburg S, Lyons JM, Land JA et al. TLR9 KO mice, haplotypes and CPG indices in Chlamydia trachomatis infection. Drugs Today (Barc) 2009; 45 (Suppl B): 83-93.
43. den Hartog JE, Morre SA, Land JA. Chlamydia trachomatis-associated tubal factor subfertility: immunogenetic aspects and serological screening. Hum Reprod Update 2006; 12: 719-730.
44. den Hartog JE, Ouburg S, Land JA et al. Do host genetic traits in the bacterial sensing system play a role in the development of Chlamydia trachomatis-associated tubal pathology in subfertile women? BMC Infect Dis 2006; 6: 122.
45. Ouburg S, Spaargaren J, den Hartog JE et al. The CD14 functional gene polymorphism -260 C>T is not involved in either the susceptibility to Chlamydia trachomatis infection or the development of tubal pathology. BMC Infect Dis 2005; 5: 114.
46. Barr EL, Ouburg S, Igietseme JU et al. Host inflammatory response and development of complications of Chlamydia trachomatis genital infection in CCR5-deficient mice and subfertile women with the CCR5delta32 gene deletion. J Microbiol Immunol Infect 2005; 38: 244-254.
47. Bailey RL, Natividad-Sancho A, Fowler A et al. Host genetic contribution to the cellular immune response to Chlamydia trachomatis: heritability estimate from a Gambian twin study. Drugs Today (Barc) 2009; 45 (Suppl B): 45-50.
48. Baud D, Goy G, Jaton K et al. Role of Chlamydia trachomatis in miscarriage. Emerg Infect Dis 2011; 17: 1630-1635.
49. Wolf K, Fischer E, Hackstadt T. Degradation of Chlamydia pneumoniae by peripheral blood monocytic cells. Infect Immun 2005; 73: 4560-4570.
50. Tamari M, Harada M, Hirota T, Nakamura Y. Host molecular defense mechanisms against Chlamydophila pneumoniae and genetic studies of immune-response-related genes in asthma. Recent Pat Inflamm Allergy Drug Discov 2009; 3: 17-25.
51. Douglas AL, Hatch TP. Expression of the transcripts of the sigma factors and putative sigma factor regulators of Chlamydia trachomatis L2. Gene 2000; 247: 209-214.
52. Asner SA, Jaton K, Kyprianidou S, Nowak AM, Greub G. Chlamydia pneumoniae: possible association with asthma in children. Clin Infect Dis 2014; 58: 1198-1199.
53. Hahn DL, Schure A, Patel K, Childs T, Drizik E, Webley W. Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity. PLoS One 2012; 7: e35945.
54. Rantala A, Lajunen T, Juvonen R et al. Low mannose-binding lectin levels and MBL2 gene polymorphisms associate with Chlamydia pneumoniae antibodies. Innate Immun 2011; 17: 35-40.
55. Rantala A, Lajunen T, Juvonen R et al. Interleukin-6-174G/C promoter polymorphism is associated with persistence of Chlamydia pneumoniae antibodies in young men. Scand J Immunol 2011; 74: 95-99.
56. Principi N, Esposito S. Mycoplasma pneumoniae and Chlamydia pneumoniae cause lower respiratory tract disease in paediatric patients. Curr Opin Infect Dis 2002; 15: 295-300.
57. Principi N, Esposito S, Blasi F, Allegra L, Mowgli study group. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. Clin Infect Dis 2001; 32: 1281-1289.
58. Esposito S, Principi N. Asthma in children: are chlamydia or mycoplasma involved? Paediatr Drugs 2001; 3: 159-168.
59. Emre U, Roblin PM, Gelling M et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 1994; 148: 727-732.
60. Martin RJ, Kraft M, Chu HW, Berns EA, Cassell GH. A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001; 107: 595-601.
61. Clifton IJ, Kastelik JA, Peckham DG et al. Ten years of viral and non-bacterial serology in adults with cystic fibrosis. Epidemiol Infect 2008; 136: 128-134.
62. Martin RJ, Chu HW, Honour JM, Harbeck RJ. Airway inflammation and bronchial hyperresponsiveness after Mycoplasma pneumoniae infection in a murine model. Am J Respir Cell Mol Biol 2001; 24: 577-582.
63. Hardy RD, Jafri HS, Olsen K et al. Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae pneumonia model: a microbiologic, histologic, immunologic, and respiratory plethysmographic profile. Infect Immun 2001; 69: 3869-3876.
64. Koh YY, Park Y, Lee HJ, Kim CK. Levels of interleukin-2, interferon-gamma, and interleukin-4 in bronchoalveolar lavage fluid from patients with Mycoplasma pneumonia: implication of tendency toward increased immunoglobulin E production. Pediatrics 2001; 107: E39.
65. Halme S, Latvala J, Karttunen R, Palatsi I, Saikku P, Surcel HM. Cell-mediated immune response during primary Chlamydia pneumoniae infection. Infect Immun 2000; 68: 7156-7158.
66. Schmidt SM, Muller CE, Bruns R, Wiersbitzky SK. Bronchial Chlamydia pneumoniae infection, markers of allergic inflammation and lung function in children. Pediatr Allergy Immunol 2001; 12: 257-265.
67. Kim CK, Chung CY, Kim JS, Kim WS, Park Y, Koh YY. Late abnormal findings on high-resolution computed tomography after Mycoplasma pneumonia. Pediatrics 2000; 105: 372-378.
68. ten Brinke A, van Dissel JT, Sterk PJ, Zwinderman AH, Rabe KF, Bel EH. Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. J Allergy Clin Immunol 2001; 107: 449-454.
69. Madariaga MG, Rezai K, Trenholme GM, Weinstein RA. Q fever: a biological weapon in your backyard. Lancet Infect Dis 2003; 3: 709-721.
70. Maurin M, Raoult D. Q fever. Clin Microbiol Rev 1999; 12: 518-553.
71. Ohguchi H, Hirabayashi Y, Kodera T, Ishii T, Munakata Y, Sasaki T. Q fever with clinical features resembling systemic lupus erythematosus. Intern Med 2006; 45: 323-326.
72. Maltezou HC, Raoult D. Q fever in children. Lancet Infect Dis 2002; 2: 686-691.
73. Leone M, Honstettre A, Lepidi H et al. Effect of sex on Coxiella burnetii infection: protective role of 17beta-estradiol. J Infect Dis 2004; 189: 339-345.
74. Delaby A, Gorvel L, Espinosa L et al. Defective monocyte dynamics in Q fever granuloma deficiency. J Infect Dis 2012; 205: 1086-1094.
75. Ghigo E, Honstettre A, Capo C, Gorvel JP, Raoult D, Mege JL. Link between impaired maturation of phagosomes and defective Coxiella burnetii killing in patients with chronic Q fever. J Infect Dis 2004; 190: 1767-1772.
76. Meghari S, Capo C, Raoult D, Mege JL. Deficient transendothelial migration of leukocytes in Q fever: the role played by interleukin-10. J Infect Dis 2006; 194: 365-369.
77. Fenollar F, Puechal X, Raoult D. Whipple's disease. N Engl J Med 2007; 356: 55-66.
78. Schneider T, Moos V, Loddenkemper C, Marth T, Fenollar F, Raoult D. Whipple's disease: new aspects of pathogenesis and treatment. Lancet Infect Dis 2008; 8: 179-190.
79. Gross JB, Wollaeger EE, Sauer WG, Huizenga KA, Dahlin DC, Power MH. Whipple's disease; report of four cases, including two in brothers, with observations on pathologic physiology, diagnosis, and treatment. Gastroenterology 1959; 36: 65-93.
80. Wilson KH, Blitchington R, Frothingham R, Wilson JA. Phylogeny of the Whipple's-disease-associated bacterium. Lancet 1991; 338: 474-475.
81. Biagi F, Badulli C, Feurle GE et al. Cytokine genetic profile in Whipple's disease. Eur J Clin Microbiol Infect Dis 2012; 31: 3145-3150.
82. Ponz de Leon M, Borghi A, Ferrara F, Contri M, Roncucci L. Whipple's disease in a father-son pair. Intern Emerg Med 2006; 1: 254-256.
83. Schinnerling K, Moos V, Geelhaar A et al. Regulatory T cells in patients with Whipple's disease. J Immunol 2011; 187: 4061-4067.